Vitamin D and glycemic control in diabetes mellitus type 2
Open Access
- 28 August 2013
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 4 (4), 122-128
- https://doi.org/10.1177/2042018813501189
Abstract
The extraskeletal effects of vitamin D have attracted considerable interest. Vitamin D deficiency appears to be related to the development of diabetes mellitus type 2 and the metabolic syndrome. Vitamin D may affect glucose homeostasis, vitamin D levels having been found to be inversely related to glycosylated hemoglobin levels in gestational diabetes mellitus. In addition, vitamin D appears to protect from the development of gestational diabetes mellitus. The aim was to study levels of 25-hydroxy vitamin D3 [25(OH)D3] and the relationship between 25(OH)D3 levels and glycemic control in patients with diabetes mellitus type 2. Glycosylated hemoglobin (HbA1c) and 25(OH)D3 levels were measured in a group of 120 diabetes mellitus type 2 patients. The same measurements were performed in a group of 120 control subjects of the same age and sex. 25(OH)D3 was measured by radioimmunoassay and glycosylated hemoglobin (HbA1c) was measured by high-performance liquid chromatography. 25(OH)D3 levels were lower in the diabetes mellitus type 2 patients than in the control group, being 19.26 ± 0.95 ng/ml and 25.49 ± 1.02 ng/ml, in the patient and control groups, respectively (p < 0.001, Student’s t-test). 25(OH)D3 levels were found to be inversely associated with HbA1c levels in the diabetic patients (p = 0.008, r2 = 0.058, linear regression). 25(OH)D3 levels were found to be inversely associated with HbA1c when the patient and control groups were analysed together (p < 0.001, r2 = 0.086). Vitamin D levels appeared to be lower in diabetes mellitus type 2 patients than in the control group, vitamin D levels being related to glycemic control in diabetes mellitus type 2. These findings may have therapeutic implications as cautious vitamin D supplementation may improve glycemic control in diabetes mellitus type 2.Keywords
This publication has 52 references indexed in Scilit:
- Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndromeNutrition Journal, 2013
- The effect of vitamin D on insulin resistance in patients with type 2 diabetesDiabetology & Metabolic Syndrome, 2013
- Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with NephropathyPLOS ONE, 2012
- Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trialDARU Journal of Pharmaceutical Sciences, 2012
- The Nonskeletal Effects of Vitamin D: An Endocrine Society Scientific StatementEndocrine Reviews, 2012
- Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional studyCardiovascular Diabetology, 2012
- Bacterial components plus vitamin D: The ultimate solution to the asthma (autoimmune disease) epidemic?Journal of Allergy and Clinical Immunology, 2011
- Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in WomenDiabetes Care, 2010
- The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of actionMolecular Aspects of Medicine, 2008
- The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2007